Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors

References

• Kronholm S, Capel P. Concentrations, loads, and yields of organic carbon in streams of agricultural watersheds. J Environ Qual 2012;41:1874–83
   PubMed Web of Science ®Google Scholar
• Wingate L, Ogee J, Cuntz M, et al. The impact of soil microorganisms on the global budget of delta18O in atmospheric CO2. Proc Natl Acad Sci USA 2009;106:22411–15
   PubMed Web of Science ®Google Scholar
• Freeman C, Kim SY, Lee SH, et al. Effects of elevated atmospheric CO2 concentrations on soil microorganisms. J Microbiol 2004;42:267–77
   PubMed Web of Science ®Google Scholar
• Johnson X, Alric J. Interaction between starch breakdown, acetate assimilation, and photosynthetic cyclic electron flow in Chlamydomonas reinhardtii. J Biol Chem 2012;287:26445–52
   PubMed Web of Science ®Google Scholar
• Tcherkez G, Boex-Fontvieille E, Mahe A, et al. Respiratory carbon fluxes in leaves. Curr Opin Plant Biol 2012;15:308–14
   PubMed Web of Science ®Google Scholar
• Casey JR. Why bicarbonate? Biochem Cell Biol 2006;84:930–9
   PubMed Web of Science ®Google Scholar
• Kozliak EI, Fuchs JA, Guilloton MB, et al. Role of bicarbonate/CO2 in the inhibition of Escherichia coli growth by cyanate. J Bacteriol 1995;177:3213–19
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discover 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med Res Rev 2003;23:535–58
   PubMed Web of Science ®Google Scholar
• Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335–66
   PubMed Web of Science ®Google Scholar
• Maeda S, Price GD, Badger MR, et al. Bicarbonate binding activity of the CmpA protein of the cyanobacterium Synechococcus sp. strain PCC 7942 involved in active transport of bicarbonate. J Biol Chem 2000;275:20551–5
   PubMed Web of Science ®Google Scholar
• Joseph P, Ouahrani-Bettache S, Montero JL, et al. A new beta-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. Bioorg Med Chem 2011;19:1172–8
   PubMed Web of Science ®Google Scholar
• Joseph P, Turtaut F, Ouahrani-Bettache S, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem 2010;53:2277–85
   PubMed Web of Science ®Google Scholar
• Djapa LY, Zelikson R, Delahodde A, et al. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs. FEMS Microbiol Lett 2006;256:105–11
   Google Scholar
• Hartman PG. Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors. J Chemother 1993;5:369–76
   PubMed Web of Science ®Google Scholar
• Chen MJ, Shimada T, Moulton AD, et al. The functional human dihydrofolate reductase gene. J Biol Chem 1984;259:3933–43
   PubMedGoogle Scholar
• Sohn KJ, Jang H, Campan M, et al. The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int J Cancer 2009;124:1999–2005
   PubMed Web of Science ®Google Scholar
• Khalil I, Ronn AM, Alifrangis M, et al. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am J Trop Med Hyg 2003;68:586–9
   PubMedGoogle Scholar
• Mockenhaupt FP, Teun Bousema J, Eggelte TA, et al. Plasmodium falciparum DHFR but not DHPS mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health 2005;10:901–8
   Google Scholar
• Benkovic SJ, Fierke CA, Naylor AM. Insights into enzyme function from studies on mutants of dihydrofolate reductase. Science 1988;239:1105–10
   PubMedGoogle Scholar
• Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:1--6
   PubMedGoogle Scholar
• Krungkrai J, Supuran CT. The alpha-carbonic anhydrase from the malaria parasite and its inhibition. Curr Pharm Des 2008;14:631–40
   PubMed Web of Science ®Google Scholar
• Reungprapavut S, Krungkrai SR, Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem 2004;19:249–56
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74
   PubMed Web of Science ®Google Scholar
• Supuran CT. Indisulam: an anticancer sulfonamide in clinical development. Expert Opin Investig Drugs 2003;12:283–7
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets—an overview. Curr Top Med Chem 2007;7:825–33
   PubMed Web of Science ®Google Scholar
• Supuran CT. Antiepileptic activity of zonisamide on hippocampal CA3 neurons does not depend on carbonic anhydrase inhibition. Epilepsy Res 2008;82:109, author reply 10
   PubMedGoogle Scholar
• Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233–45
   PubMed Web of Science ®Google Scholar
• Brown GM. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem 1962;237:536–40
   PubMed Web of Science ®Google Scholar
• Shiota T, Disraely MN, McCann MP. The enzymatic synthesis of folate-like compounds from hydroxymethyldihydropteridine pyrophosphate. J Biol Chem 1964;239:2259–66
   Google Scholar
• Shiota T, Baugh CM, Jackson R, et al. The enzymatic synthesis of hydroxymethyldihydropteridine pyrophosphate and dihydrofolate. Biochemistry 1969;8:5022–8
   PubMed Web of Science ®Google Scholar
• Valderas MW, Andi B, Barrow WW, et al. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase. Biochim Biophys Acta 2008;1780:848–53
   PubMed Web of Science ®Google Scholar
• Lopez P, Espinosa M, Greenberg B, et al. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme. J Bacteriol 1987;169:4320–6
   PubMed Web of Science ®Google Scholar
• Slock J, Stahly DP, Han CY, et al. An apparent Bacillus subtilis folic acid biosynthetic operon containing pab, an amphibolic trpG gene, a third gene required for synthesis of para-aminobenzoic acid, and the dihydropteroate synthase gene. J Bacteriol 1990;172:7211–26
   PubMed Web of Science ®Google Scholar
• Radstrom P, Swedberg G. RSF1010 and a conjugative plasmid contain sulII, one of two known genes for plasmid-borne sulfonamide resistance dihydropteroate synthase. Antimicrob Agents Chemother 1988;32:1684–92
   PubMed Web of Science ®Google Scholar
• Sundstrom L, Radstrom P, Swedberg G, et al. Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. Mol Gen Genet 1988;213:191–201
   PubMedGoogle Scholar
• Morgan RE, Batot GO, Dement JM, et al. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate. BMC Struct Biol 2011;11:1--9
   Google Scholar
• Blakley RL. Eukaryotic dihydrofolate reductase. Adv Enzymol Relat Areas Mol Biol 1995;70:23–102
   PubMedGoogle Scholar
• Heaslet H, Harris M, Fahnoe K, et al. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim. Proteins 2009;76:706–17
   PubMed Web of Science ®Google Scholar
• Pan YC, Domin BA, Li SS, et al. Studies of amino-acid sequence in dihydrofolate reductase from a human methotrexate-resistant cell line KB/6b. Structural and kinetic comparison with mouse L1210 enzyme. Eur J Biochem 1983;132:351–9
   Google Scholar
• Kovalevskaya NV, Smurnyy YD, Polshakov VI, et al. Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH. J Biomol NMR 2005;33:69–72
   PubMed Web of Science ®Google Scholar
• Cody V, Luft JR, Ciszak E, et al. Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and methotrexate-gamma-tetrazole. Anticancer Drug Des 1992;7:483–91
   PubMedGoogle Scholar
• Cody V, Wojtczak A, Kalman TI, et al. Conformational analysis of human dihydrofolate reductase inhibitor complexes: crystal structure determination of wild type and F31 mutant binary and ternary inhibitor complexes. Adv Exp Med Biol 1993;338:481–6
   Google Scholar
• Jensen DE, Black AR, Swick AG, et al. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem 1997;67:24–31
   PubMed Web of Science ®Google Scholar
• Curtius HC, Heintel D, Ghisla S, et al. Tetrahydrobiopterin biosynthesis. Studies with specifically labeled (2H)NAD(P)H and 2H2O and of the enzymes involved. Eur J Biochem 1985;148:413–19
   PubMedGoogle Scholar
• Kim HL, Choi YK, Kim do H, et al. Tetrahydropteridine deficiency impairs mitochondrial function in Dictyostelium discoideum Ax2. FEBS Lett 2007;581:5430–4
   Google Scholar
• Channon KM. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 2004;14:323–7
   PubMed Web of Science ®Google Scholar
• Huovinen P, Sundstrom L, Swedberg G, et al. Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 1995;39:279–89
   PubMed Web of Science ®Google Scholar
• Huovinen RL, Alanen KA, Collan YU. Cell proliferation in dimethylbenz(A)anthracene(DMBA)-induced rat mammary carcinoma treated with antiestrogen toremifene. Acta Oncol 1995;34:479–85
   PubMed Web of Science ®Google Scholar
• Kehrenberg C, Schwarz S. dfrA20, A novel trimethoprim resistance gene from Pasteurella multocida. Antimicrob Agents Chemother 2005;49:414–17
   Google Scholar
• Alonso H, Gready JE. Integron-sequestered dihydrofolate reductase: a recently redeployed enzyme. Trends Microbiol 2006;14:236–42
   Google Scholar
• Dale GE, Broger C, D'Arcy A, et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J Mol Biol 1997;266:23–30
   PubMed Web of Science ®Google Scholar
• Howell EE. Searching sequence space: two different approaches to dihydrofolate reductase catalysis. Chem Biochem 2005;6:590–600
   Google Scholar
• Skold O. Resistance to trimethoprim and sulfonamides. Vet Res 2001;32:261–73
   PubMed Web of Science ®Google Scholar
• Domagk G. [Experimental bases in chemotherapy of bacterial infections with sulfonamides and related substances with special reference to its application in surgery]. Langenbecks Archiv fur klinische Chirurgie vereinigt mit Deutsche Zeitschrift fur Chirurgie 1950;264:102–23
   Google Scholar
• Tréfouël JT, Nitti F, Bovet D. Activité du p.aminophénylsulfamide sur l’infection streptococcique expérimentale de la souris et du lapin. C R Soc Biol 1935;120:756–61
   Google Scholar
• Hawser S, Lociuro S, Islam K. Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol 2006;71:941–8
   PubMed Web of Science ®Google Scholar
• Yun MK, Wu Y, Li Z, et al. Catalysis and sulfa drug resistance in dihydropteroate synthase. Science 2012;335:1110–14
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49:2117–26
   PubMed Web of Science ®Google Scholar
• Chirica LC, Petersson C, Hurtig M, et al. Expression and localization of alpha- and beta-carbonic anhydrase in Helicobacter pylori. Biochim Biophys Acta 2002;1601:192–9
   PubMed Web of Science ®Google Scholar
• Del Prete S, Isik S, Vullo D, et al. DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 2012;55:10742–8
   PubMed Web of Science ®Google Scholar
• Vullo D, Isik S, Del Prete S, et al. Anion inhibition studies of the alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem Lett 2013;23:1636–8
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Scozzafava A, et al. Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides. Bioorg Med Chem Lett 2010;20:2178–82
   PubMed Web of Science ®Google Scholar
• Dini L, du Plessis M, Frean J, et al. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol 2010;48:2016–21
   PubMed Web of Science ®Google Scholar
• Tadesse DA, Zhao S, Tong E, et al. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerg Infect Dis 2012;18:741–9
   PubMed Web of Science ®Google Scholar
• Tauber MG, Muhlemann K. Antibiotic therapy in the outpatient setting: update 2009. Praxis 2009;98:877–83
   Google Scholar
• Mastrolorenzo A, Supuran CT. Antifungal activity of Ag(I) and Zn(II) complexes of sulfacetamide derivatives. Met Based Drugs 2000;7:49–54
   PubMedGoogle Scholar
• Yoneyama H, Katsumata R. Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 2006;70:1060–75
   PubMed Web of Science ®Google Scholar